Chris Hall, CEO and President, Personalis Inc. – A Prescription for Prosperity: Fueling medical breakthroughs with cutting-edge tech and strategic alliances
03/27/24 • 29 min
Big healthcare challenges demand cutting-edge healthcare products. Today's guest is building strategic partnerships to get ahead of disease and fuel the growth of their company.
Today we're sitting down with Chris Hall, CEO and President of Personalis, which trades under the symbol PSNL. In his role, Chris drives the vision and strategy for the company, including commercializing its diagnostic product offerings. He brings over 20 years of experience in general management and product development within the diagnostics industry, most recently as CEO of Naring Health.
Previously he served as President, COO, and Chief Commercial Officer of Veracyte Inc, where he led the company's commercial entry into endocrinology and pulmonology and scaled its operational groups. Chris also served as an SVP and Chief Business Officer at Berkeley HeartLab, part of Celera Corporation, where he helped new product launches, and restructured operations to improve profitability and streamline delivery of services.
Chris holds a BA in political science from DePauw University and an MBA from Harvard.
Highlights:
- Chris describes Personalis and their work (3:45)
- Personalis' MRD test and how it works (6:25)
- Chris walks us through Personalis' tech evolution (8:23)
- Personalis' current partnerships and collaborations (10:24)
- More about the internal team at Personalis (14:31)
- Chris discusses Personalis' recent Medicare coverage announcement (16:09)
- The current macro environment's effect on business (18:09)
- 2023 highlights at Personalis (19:54)
- Near-future growth and development goals for Personalis (22:25)
- Leadership and company culture at Personalis (24:22)
- Product development and long-term objectives (26:19)
Links:
Feedback:
If you have questions about the show, or have a topic in mind you'd like discussed in future episodes, email our producer, [email protected].
Big healthcare challenges demand cutting-edge healthcare products. Today's guest is building strategic partnerships to get ahead of disease and fuel the growth of their company.
Today we're sitting down with Chris Hall, CEO and President of Personalis, which trades under the symbol PSNL. In his role, Chris drives the vision and strategy for the company, including commercializing its diagnostic product offerings. He brings over 20 years of experience in general management and product development within the diagnostics industry, most recently as CEO of Naring Health.
Previously he served as President, COO, and Chief Commercial Officer of Veracyte Inc, where he led the company's commercial entry into endocrinology and pulmonology and scaled its operational groups. Chris also served as an SVP and Chief Business Officer at Berkeley HeartLab, part of Celera Corporation, where he helped new product launches, and restructured operations to improve profitability and streamline delivery of services.
Chris holds a BA in political science from DePauw University and an MBA from Harvard.
Highlights:
- Chris describes Personalis and their work (3:45)
- Personalis' MRD test and how it works (6:25)
- Chris walks us through Personalis' tech evolution (8:23)
- Personalis' current partnerships and collaborations (10:24)
- More about the internal team at Personalis (14:31)
- Chris discusses Personalis' recent Medicare coverage announcement (16:09)
- The current macro environment's effect on business (18:09)
- 2023 highlights at Personalis (19:54)
- Near-future growth and development goals for Personalis (22:25)
- Leadership and company culture at Personalis (24:22)
- Product development and long-term objectives (26:19)
Links:
Feedback:
If you have questions about the show, or have a topic in mind you'd like discussed in future episodes, email our producer, [email protected].
Previous Episode
David Bandele, CFO, Hexagon Composites – Energizing the Industry: Fueling growth by tapping into a sustainable future and a vast market
There are some extraordinary opportunities for companies with the vision and commitment to get behind the energy transition, and today's guest works with one of them.
We're sitting down with David Bandele, who has served as the CFO of Hexagon Composites since 2014. The company is headquartered in Norway and trades under the symbol H E X . O L. Their business is focused on carbon-negative, zero-emission energy solutions supported by world-class manufacturing and digitization.
Before joining Hexagon, David held several senior positions in the field of finance and controlling with the Acre Group of Companies, GE Healthcare, and Amersham PLC. He holds a Bachelor of Economics from the University of Sheffield and is an ICAEW Chartered Accountant.
Highlights:
- Introduction to Hexagon Composites and their background (3:24)
- Hexagon's target audience and reach (4:24)
- David describes his road to Hexagon (4:51)
- David breaks down the similarities and differences between natural gas, and renewable gas (6:03)
- Hexagon's growth and quick expansion (8:02)
- Hexagon's total addressable market and sustainability benefits (11:43)
- David walks us through Hexagon Agility's mobile pipeline (15:34)
- Mobile pipeline demand (17:17)
- David takes us through the roll out of Hexagon Digital Wave and developments in other Hexagon verticals (18:11)
- Hexagon's recent partnership with Compass Natural Gas (19:45)
- The projects of Hexagon Purus (20:45)
- Hexagon Ragasco and their current market outlook (22:26)
- David gives his outlook on the current environmental and sustainability efforts in business across North America (24:20)
- How Hexagon is continuing to innovate and win over shareholders for the long term (25:59)
- David gives us his predictions and goals for Hexagon's near future (28:42)
Links:
Hexagon Composites on LinkedIn
Feedback:
If you have questions about the show, or have a topic in mind you'd like discussed in future episodes, email our producer, [email protected].
Next Episode
Jake Karls, Co-Founder & Rainmaker, Mid-Day Squares – Bittersweet Victory: Showcasing challenges and successes in the entrepreneurial journey
Introducing a new product into the extremely competitive snack market is not for the faint of heart. To succeed, you need more than a unique product; you need energy, creativity, and a bold approach. Today’s guest has all that in spades.
We're sitting down with Jake Karls, who is the first to admit that he's a different kind of business leader, unapologetically authentic, refreshingly relatable, and completely free of bullshit. Jake is the Co-Founder and Chief Rainmaker of Mid-Day Squares, the good-for-you chocolate brand that turned a kitchen table dream into a global household name.
Mid-Day Squares is leading the disruption of an extremely competitive vertical with a winning team, innovative marketing and a fearless spirit. Jake is recognized as a rising star in the business world, was a finalist for Ian Wise Entrepreneur of the Year Award, was named to Forbes’ 30 under 30 List for food and beverage, and has featured as a regular contributor to media outlets across North America.
Jake has also nicknamed the ICR conference The House of Capital, and we love him for that. He’s officially a “FOICR” which stands for Friend of ICR.
Highlights:
- Jake discusses his path into the business sector (3:57)
- Jake and Tom talk about their favorite Shark Tank Shark (6:51)
- Jake talks about failure, finding work purpose, and skill sets (7:35)
- Finding your niche in a competitive market, and Mid-Day Squares' social media approach to branding, and (9:57)
- Building a brand with emotional connection, and modernized marketing (12:10)
- Mid-Day Squares' conception and the idea behind the product (14:15)
- Jake and the team's experience with manufacturing and building their own facility (16:12)
- Best-selling products (19:02)
- Mid-Day Squares' retail connections and their proudest deal (19:45)
- Refrigerated snacking, and how Mid-Day Squares target their audiences (21:00)
- How the team balances retail and direct channels (22:55)
- Goal and mission of Mid-Day Squares (24:00)
- Jake explains the complexity and challenges in the CPG (consumer packaged goods) industry (25:21)
- Jake gets honest about building your own business (26:35)
- Ideas for near-future product extensions at Mid-Day Squares (27:57)
- How much capital Mid-Day has raised for growth and development (29:13)
Links:
Feedback:
If you have questions about the show, or have a topic in mind you'd like discussed in future episodes, email our producer, [email protected].
If you like this episode you’ll love
Episode Comments
Generate a badge
Get a badge for your website that links back to this episode
<a href="https://goodpods.com/podcasts/welcome-to-the-arena-from-icr-conversations-with-todays-innovators-and-419369/chris-hall-ceo-and-president-personalis-inc-a-prescription-for-prosper-58114133"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to chris hall, ceo and president, personalis inc. – a prescription for prosperity: fueling medical breakthroughs with cutting-edge tech and strategic alliances on goodpods" style="width: 225px" /> </a>
Copy